Structure determination of human and murine β‐defensins reveals structural conservation in the absence of significant sequence similarity

Defensins are cationic and cysteine‐rich peptides that play a crucial role in the host defense against microorganisms of many organisms by their capability to permeabilize bacterial membranes. The low sequence similarity among the members of the large mammalian β‐defensin family suggests that their antimicrobial activity is largely independent of their primary structure. To investigate to what extent these defensins share a similar fold, the structures of the two human β‐defensins, hBD‐1 and hBD‐2, as well as those of two novel murine defensins, termed mBD‐7 and mBD‐8, were determined by nuclear magnetic resonance spectroscopy. All four defensins investigated share a striking similarity on the level of secondary and tertiary structure including the lack of a distinct hydrophobic core, suggesting that the fold is mainly stabilized by the presence of three disulfide bonds. In addition to the overall shape of the molecules, the ratio of solvent‐exposed polar and hydrophobic side chains is also very similar among the four defensins investigated. It is significant that β‐defensins do not exhibit a common pattern of charged and hydrophobic residues on the protein surface and that the β‐defensin‐specific fold appears to accommodate a wide range of different amino acids at most sequence positions. In addition to the implications for the mode of biological defensin actions, these findings are of particular interest because β‐defensins have been suggested as lead compounds for the development of novel peptide antibiotics for the therapy of infectious diseases.

[1]  J. Schröder,et al.  Isolation and Characterization of Human β-Defensin-3, a Novel Human Inducible Peptide Antibiotic* , 2001, The Journal of Biological Chemistry.

[2]  H. G. Boman,et al.  Peptide antibiotics and their role in innate immunity. , 1995, Annual review of immunology.

[3]  M. Vaara,et al.  Agents that increase the permeability of the outer membrane. , 1992, Microbiological reviews.

[4]  R. Hancock,et al.  Cationic bactericidal peptides. , 1995, Advances in microbial physiology.

[5]  M. Selsted,et al.  Characterization of the disulfide motif in BNBD-12, an antimicrobial beta-defensin peptide from bovine neutrophils. , 1993, The Journal of biological chemistry.

[6]  H. Nomiyama,et al.  Identification of CCR6, the Specific Receptor for a Novel Lymphocyte-directed CC Chemokine LARC* , 1997, The Journal of Biological Chemistry.

[7]  Wayne L. Smith,et al.  Purification, primary structures, and antibacterial activities of β-defensins, a new family of antimicrobial peptides from bovine neutrophils. , 1996, The Journal of Biological Chemistry.

[8]  A. Foussat,et al.  Regulation of CCR6 chemokine receptor expression and responsiveness to macrophage inflammatory protein-3alpha/CCL20 in human B cells. , 2000, Blood.

[9]  Rainer Hedrich,et al.  Identification of a novel, multifunctional β-defensin (human β-defensin 3) with specific antimicrobial activity , 2001, Cell and Tissue Research.

[10]  A. Pardi,et al.  Solution structure of bovine neutrophil beta-defensin-12: the peptide fold of the beta-defensins is identical to that of the classical defensins. , 1995, Biochemistry.

[11]  G. Diamond,et al.  β-defensins: Endogenous antibiotics of the innate host defense response , 1998 .

[12]  P. Kuchel,et al.  Defensin-like peptide-2 from platypus venom: member of a class of peptides with a distinct structural fold. , 2000, The Biochemical journal.

[13]  M. Raida,et al.  hBD-1: a novel beta-defensin from human plasma. , 1995, FEBS letters.

[14]  C Sander,et al.  Mapping the Protein Universe , 1996, Science.

[15]  M Nilges,et al.  A calculation strategy for the structure determination of symmetric demers by 1H NMR , 1993, Proteins.

[16]  Rainer Fuchs,et al.  CLUSTAL V: improved software for multiple sequence alignment , 1992, Comput. Appl. Biosci..

[17]  M. Billeter,et al.  MOLMOL: a program for display and analysis of macromolecular structures. , 1996, Journal of molecular graphics.

[18]  J. Thornton,et al.  PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .

[19]  G. K. Johnson,et al.  Production of β-Defensin Antimicrobial Peptides by the Oral Mucosa and Salivary Glands , 1999, Infection and Immunity.

[20]  H Oschkinat,et al.  Improved strategies for the determination of protein structures from NMR data: The solution structure of acyl carrier protein , 1989, FEBS letters.

[21]  Hydrophobic core substitutions in calbindin D9k: effects on stability and structure. , 1998, Biochemistry.

[22]  T. Gibson,et al.  Structure of the dsRNA binding domain of E. coli RNase III. , 1995, The EMBO journal.

[23]  M. Selsted,et al.  Purification, primary structures, and antibacterial activities of beta-defensins, a new family of antimicrobial peptides from bovine neutrophils. , 1993, The Journal of biological chemistry.

[24]  T. Morton,et al.  Expression of the Antimicrobial Peptide, Human β-defensin 1, in Duct Cells of Minor Salivary Glands and Detection in Saliva , 2000, Journal of dental research.

[25]  G J Barton,et al.  ALSCRIPT: a tool to format multiple sequence alignments. , 1993, Protein engineering.

[26]  R I Lehrer,et al.  Primary structures of three human neutrophil defensins. , 1985, The Journal of clinical investigation.

[27]  J. Schröder,et al.  Human beta-defensin-2. , 1999, The international journal of biochemistry & cell biology.

[28]  T. Ganz,et al.  The NMR Structure of Human β-Defensin-2 Reveals a Novel α-Helical Segment†,‡ , 2001 .

[29]  A. Gronenborn,et al.  Determination of three-dimensional structures of proteins by simulated annealing with interproton distance restraints. Application to crambin, potato carboxypeptidase inhibitor and barley serine proteinase inhibitor 2. , 1988, Protein engineering.

[30]  M. Kagnoff,et al.  Regulation of Human β-Defensins by Gastric Epithelial Cells in Response to Infection with Helicobacter pylori or Stimulation with Interleukin-1 , 2000, Infection and Immunity.

[31]  K. Rabe,et al.  Defensins: key players or bystanders in infection, injury, and repair in the lung? , 1999, The Journal of allergy and clinical immunology.

[32]  P. Kraulis A program to produce both detailed and schematic plots of protein structures , 1991 .

[33]  P. Kuchel,et al.  Solution structure of a defensin-like peptide from platypus venom. , 1999, The Biochemical journal.

[34]  T. Ganz,et al.  Defensins and innate host defence of the gastrointestinal tract , 1999, Gut.

[35]  K. Wüthrich NMR of proteins and nucleic acids , 1988 .

[36]  A. Gronenborn,et al.  Improving the quality of NMR and crystallographic protein structures by means of a conformational database potential derived from structure databases , 1996, Protein science : a publication of the Protein Society.

[37]  R. Bals,et al.  Human β‐defensin 4: a novel inducible peptide with a specific salt‐sensitive spectrum of antimicrobial activity , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[38]  T. Ganz,et al.  The NMR structure of human beta-defensin-2 reveals a novel alpha-helical segment. , 2001, Biochemistry.

[39]  M. Selsted,et al.  Primary structures of MCP-1 and MCP-2, natural peptide antibiotics of rabbit lung macrophages. , 1983, The Journal of biological chemistry.

[40]  Robert Blumenthal,et al.  The Structure of Human β-Defensin-2 Shows Evidence of Higher Order Oligomerization* , 2000, The Journal of Biological Chemistry.

[41]  M. Selsted,et al.  Determination of the disulfide array in the human defensin HNP-2. A covalently cyclized peptide. , 1989, The Journal of biological chemistry.

[42]  G. K. Johnson,et al.  Production of beta-defensin antimicrobial peptides by the oral mucosa and salivary glands. , 1999, Infection and immunity.

[43]  E A Merritt,et al.  Raster3D Version 2.0. A program for photorealistic molecular graphics. , 1994, Acta crystallographica. Section D, Biological crystallography.

[44]  M. Raida,et al.  hBD‐1: a novel β‐defensin from human plasma , 1995 .

[45]  Ji Ming Wang,et al.  β-Defensins: Linking Innate and Adaptive Immunity Through Dendritic and T Cell CCR6 , 1999 .

[46]  Á. Zaballos,et al.  NMR Solution Structure of Murine CCL20/MIP-3α, a Chemokine That Specifically Chemoattracts Immature Dendritic Cells and Lymphocytes through Its Highly Specific Interaction with the β-Chemokine Receptor CCR6* , 2001, The Journal of Biological Chemistry.

[47]  Mark J Howard,et al.  Protein NMR spectroscopy , 1998, Current Biology.

[48]  A. Foussat,et al.  Regulation of CCR6 chemokine receptor expression and responsiveness to macrophage inflammatory protein-3alpha/CCL20 in human B cells. , 2000, Blood.